Finding of endocannabinoids in human eye tissues: Implications for glaucoma
Author:
June Chen, Isabel Matias, Tim Dinh, Ta Lu, Sonia Venezia, Amelia Nieves, David F. Woodward, Vincenzo Di Marzo
Published in Science Direct
May 2005
Abstract
Cannabinoid CB1 receptors are involved in ocular physiology and may regulate intraocular pressure (IOP). However, endocannabinoid levels in human ocular tissues of cornea, iris, ciliary body, retina, and choroid from normal and glaucomatous donors have not been investigated. Anandamide (N-arachidonoylethanolamine; AEA), 2-arachidonoylglycerol (2-AG), and the anandamide congener, palmitoylethanolamide (PEA), were detected in all the human tissues examined. In eyes from patients with glaucoma, significantly decreased 2-AG and PEA levels were detected in the ciliary body, an important tissue in the regulation of IOP. The findings suggest that these endogenous compounds may have a role in this disease, particularly with respect to regulation of IOP.
Open Access
DOI: doi.org/10.1016/j.bbrc.2005.03.095
Citation:
San Luis, C. V., Nobleza, C. O. H. S., Shekhar, S., Sugg, R., Villareal, D. J., Mehta, T., & Gangadhara, S. (2020). Association Between Recent Cannabinoid Use and Acute Ischemic Stroke. Neurology: Clinical Practice.